Ibnsina Pharma (EGX:ISPH)

Market Cap	10.59B
Revenue (ttm)	68.07B
Net Income (ttm)	633.24M
Shares Out	1.01B
EPS (ttm)	0.63
PE Ratio	16.73
Forward PE	8.70
Dividend	0.16 (1.50%)
Ex-Dividend Date	Oct 13, 2025

Volume	5,262,780
Average Volume	5,382,182
Open	10.64
Previous Close	10.64
Day's Range	10.44 - 10.74
52-Week Range	5.36 - 12.30
Beta	0.59
RSI	32.83
Earnings Date	Nov 11, 2025

About Ibnsina Pharma

Ibnsina Pharma operates as a pharmaceutical distributor in Egypt. The company offers pharmaceutical and cosmetics products to private and public-sector customers, including retail chains, independent pharmacies, wholesalers, hospitals, and healthcare institutions. It also provides warehousing and logistic services for its suppliers; marketing solutions; importation and packaging services; and market research and analysis services, as well as value added services. The company was founded in 2001 and is headquartered in El Obour City, Egypt.

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2001
• Employees: 5,500
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: ISPH

Financial Performance

In 2024, Ibnsina Pharma's revenue was 55.84 billion, an increase of 64.49% compared to the previous year's 33.95 billion. Earnings were 497.80 million, an increase of 187.51%.